Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study
Journal article published in 2020 by
Feng Wang,
Tian-Shu Liu,
Xiang-Lin Yuan,
Hui-Yan Luo 
,
Kang-Sheng Gu,
Ying Yuan,
Yan-Hong Deng,
Jian-Ming Xu,
Yu-Xian Bai,
Ying Wang,
Wang-Jun Liao,
He-Long Zhang,
Feng Bi,
Bang-Mao Wang,
Zhi-Xiang Zhuang
and other authors.
,
Kang-Sheng Gu,
Ying Yuan,
Yan-Hong Deng,
Jian-Ming Xu,
Yu-Xian Bai,
Ying Wang,
Wang-Jun Liao,
He-Long Zhang,
Feng Bi,
Bang-Mao Wang,
Zhi-Xiang Zhuang
and other authors.
